Canadian recreational legalization in late October may come to be seen as the highlight of the cannabis year, but in Europe, the fourth quarter tops off quite an amazing 2018 too.
The country wants to put itself on the map as the recreational “icebreaker” of Europe per comments of a leading consumer rights group.
Representatives from the leading accreditation bodies met for a panel at the Food Safety Consortium where they discussed the new ISO standard, the future of the cannabis lab industry and certifications for food safety and quality.
The cultivation bid has already been stalled in federal court once and Round II is shaping up to be just as fractious. Is there any end to the drama in sight?
Starting January 1, California’s cannabis operators must adhere to strict compliance guidelines that include oversight by the state’s new track-and-trace system, Metrc. Failure to do so puts businesses at risk of criminal liabilities and has the potential to invite federal prosecution.
Massachusetts gave the green light to dispensaries last week, opening up the first recreational cannabis market on the East Coast.
Patients can now get medical cannabis by prescription in the UK. But what does a Schedule II prescription issuance really mean? A few lessons from Germany and other places…
As the German cultivation bid deadline ticks down, the big Canadian LPs are solidifying their presence in Germany and far beyond across Europe. Two in particular have made major announcements last week, coming hot on the heels of Aurora’s Polish expansion.
Denmark’s foray into medical cannabis is quietly picking up steam, albeit tightly regulated.
The first ISO 17025-accredited cannabis testing lab in Florida opened their second location in Gainesville and are on track to expand further.
